Fable Zustovich

2.0k total citations
87 papers, 949 citations indexed

About

Fable Zustovich is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Fable Zustovich has authored 87 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Fable Zustovich's work include Cancer Treatment and Pharmacology (19 papers), Renal cell carcinoma treatment (18 papers) and Glioma Diagnosis and Treatment (17 papers). Fable Zustovich is often cited by papers focused on Cancer Treatment and Pharmacology (19 papers), Renal cell carcinoma treatment (18 papers) and Glioma Diagnosis and Treatment (17 papers). Fable Zustovich collaborates with scholars based in Italy, United States and United Kingdom. Fable Zustovich's co-authors include Giuseppe Lombardi, Davide Pastorelli, Vittorina Zagonel, Alessandro Della Puppa, Patrizia Farina, Martin Donach, Renato Scienza, Grazia Artioli, Maria Ornella Nicoletto and G. Cartei and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Molecular Sciences.

In The Last Decade

Fable Zustovich

81 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fable Zustovich Italy 18 528 317 298 214 207 87 949
Marco Bartolotti Italy 18 554 1.0× 446 1.4× 214 0.7× 143 0.7× 252 1.2× 33 897
Ya-Yu Tsai United States 17 555 1.1× 411 1.3× 216 0.7× 125 0.6× 357 1.7× 72 1.0k
Andrea Fontana Italy 19 335 0.6× 549 1.7× 285 1.0× 238 1.1× 127 0.6× 50 1.0k
K. Chao United States 14 304 0.6× 273 0.9× 204 0.7× 182 0.9× 246 1.2× 34 873
Lidia Gatto Italy 21 450 0.9× 342 1.1× 326 1.1× 290 1.4× 334 1.6× 83 1.2k
Aysegül Ilhan‐Mutlu Austria 20 712 1.3× 668 2.1× 371 1.2× 239 1.1× 275 1.3× 71 1.4k
J. Biau France 20 471 0.9× 440 1.4× 340 1.1× 147 0.7× 283 1.4× 113 1.3k
Voichita Bar‐Ad United States 21 447 0.8× 514 1.6× 330 1.1× 230 1.1× 149 0.7× 98 1.4k
Jill Hagenkord United States 19 293 0.6× 216 0.7× 380 1.3× 336 1.6× 174 0.8× 32 985
José Pablo Leone United States 21 551 1.0× 716 2.3× 204 0.7× 365 1.7× 140 0.7× 88 1.3k

Countries citing papers authored by Fable Zustovich

Since Specialization
Citations

This map shows the geographic impact of Fable Zustovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fable Zustovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fable Zustovich more than expected).

Fields of papers citing papers by Fable Zustovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fable Zustovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fable Zustovich. The network helps show where Fable Zustovich may publish in the future.

Co-authorship network of co-authors of Fable Zustovich

This figure shows the co-authorship network connecting the top 25 collaborators of Fable Zustovich. A scholar is included among the top collaborators of Fable Zustovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fable Zustovich. Fable Zustovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reni, Michele, Guido Giordano, Marina Macchini, et al.. (2024). Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life. Digestive and Liver Disease. 57(1). 104–110.
2.
Pasello, Giulia, Aline S.C. Fabricio, Paola Del Bianco, et al.. (2024). Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients. Journal of Translational Medicine. 22(1). 242–242. 7 indexed citations
4.
Maruzzo, Marco, Umberto Basso, Eugenio Borsatti, et al.. (2018). Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region. Clinical Genitourinary Cancer. 17(1). e187–e194. 14 indexed citations
5.
Buti, Sebastiano, Melissa Bersanelli, Francesca Maines, et al.. (2016). First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study. Clinical Genitourinary Cancer. 15(4). e609–e614. 39 indexed citations
6.
Zustovich, Fable, Alessandra Ferro, & Patrizia Farina. (2014). Bevacizumab as First-Line Therapy for Patients With Brain Metastases From Renal Carcinoma: A Case Series. Clinical Genitourinary Cancer. 12(3). e107–e110. 5 indexed citations
7.
Zustovich, Fable, Alessandra Ferro, Giuseppe Lombardi, Patrizia Farina, & Vittorina Zagonel. (2014). Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results. Chemotherapy. 60(5-6). 294–299. 13 indexed citations
8.
Zustovich, Fable & Giacomo Novara. (2013). Advanced kidney cancer: treating the elderly. Expert Review of Anticancer Therapy. 13(12). 1389–1398. 3 indexed citations
9.
Lombardi, Giuseppe, Roberta Bertorelle, Daniela Saggioro, et al.. (2013). Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment. American Journal of Clinical Oncology. 38(5). 514–519. 41 indexed citations
10.
Lombardi, Giuseppe, Fable Zustovich, Patrizia Farina, et al.. (2012). Cilengitide in bevacizumab-refractory high-grade glioma. Anti-Cancer Drugs. 23(7). 749–753. 2 indexed citations
11.
Caffo, Orazio, Teodoro Sava, Evi Comploj, et al.. (2011). Impact of docetaxel‐based chemotherapy on quality of life of patients with castration‐resistant prostate cancer: results from a prospective phase II randomized trial. British Journal of Urology. 108(11). 1825–1832. 20 indexed citations
12.
Zustovich, Fable, Giuseppe Lombardi, Ornella Nicoletto, & Davide Pastorelli. (2011). Second-line therapy for refractory renal-cell carcinoma. Critical Reviews in Oncology/Hematology. 83(1). 112–122. 13 indexed citations
13.
Lombardi, Giuseppe, Fable Zustovich, Alessandro Della Puppa, et al.. (2010). Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma. Journal of Neuro-Oncology. 104(1). 381–386. 14 indexed citations
14.
Lombardi, Giuseppe, Fable Zustovich, Fabio Farinati, et al.. (2010). Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma. Cancer. 117(1). 125–133. 40 indexed citations
15.
Nicoletto, Maria Ornella, Roberta Bertorelle, Gian Luca De Salvo, et al.. (2009). Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer. International Journal of Gynecological Cancer. 19(6). 1022–1028. 9 indexed citations
16.
Puppa, Alessandro Della, Stefania Zovato, Enrico Orvieto, et al.. (2009). Solitary intra-ventricular brain metastasis from a breast carcinoma. Journal of Neuro-Oncology. 97(1). 123–126. 15 indexed citations
17.
Cecchin, Diego, Sotirios Chondrogiannis, Alessandro Della Puppa, et al.. (2009). Presurgical 99mTc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours. Nuclear Medicine Communications. 30(9). 660–668. 6 indexed citations
18.
Pastorelli, Davide, Fable Zustovich, Giovanni Faggioni, et al.. (2009). Good response to second-line bevacizumab and interferon-α in a sunitinib-refractory patient with metastatic renal cell carcinoma. Anti-Cancer Drugs. 21(2). 210–213. 5 indexed citations
19.
Zustovich, Fable, et al.. (2008). Metastatic oligodendrogliomas: a review of the literature and case report. Acta Neurochirurgica. 150(7). 699–703. 31 indexed citations
20.
Caffo, Orazio, Teodoro Sava, Evi Comploj, et al.. (2008). Docetaxel, with or without estramustine phosphate, as first‐line chemotherapy for hormone‐refractory prostate cancer: results of a multicentre, randomized phase II trial. British Journal of Urology. 102(9). 1080–1085. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026